1. Piac és Profit: Te is lehetsz startup konferencia 2014 Április Spinoffolás két KKV példán keresztül Darvas, Board Member, ThalesNano Group

2. The Innovation and spinoff series: Thalesnano Group Drug Development or TechnologyDevelopment Companies CompuDrug, Founded in 1983 US, AZ First in developing artifical intelligenece software solutions to the pharmaceurtical research ComGenex Inc, Founded in 1992 Budapest, HU Drug discovery service company, with a high throughut screening technology Had a trade sale in 2006 to Albany Molecular (Nasdad listed) ThalesNano Inc, Spinout in 2002, Budapest- New Jersey-San Diego – London Pioneer of the flowchemistry instrumentation, which helps chemical transformations in chemistry labs. Currently employs close to 100 people, Worldwide distribution, over USD 9 mln turnover. NanGenex Inc. Spinout in 2007 NanoForm Tehrapeutics Ltd Spinout in 2010 Merged into Druggability Technology 2012 NanGenex is a developer of a propriatory nanoisation technology used for nanising API (active phramaceutical ingredients). NanoForm Tehraputics is a licensor company utilizing and developing further these technologies. Recently acquired GBP1.3 mln Jeremie investment from a Dutch Fund. ComInnex and Darholding, Founded in 2006 Fund management and innovation management companies Nuformix Ltd Cambrige, UK Lagrest investor in a JV, focusing the development of a technology for co- crystallisation of drug molecules. Management Profile Companies ComInnex and Darholding, Founded in 2006 Fund management and innovation management companies Natural healthcare Company Aromax Inc, Founded in 1992, Budapest, HU At the opening of the natural healtcare market, we were the first to build a brand and acquired majority market share. Still market leader in Hungary.

3. In medias res: the continous innovation and spin-out model Nanofom UK, 2009 Nanofom UK, 2009 ThalesNano 2002 Nangenex 2008 Druggabblilty IR, 2012 Agrothetis US, 2012 Aromax, 1992 Nanokozmetika 2014 Private Investment Series Dutch VC Fund US Private Equity IPO at AIMS? ComGeneX 1992 ComGeneX 1992 Exit: 2006 AMRI Exit: 2006 AMRI Relaunch: ComInnex Internal Fund CompuDurg 1985 Investment: Nuformix UK, 2009

4. Who are we? ThalesNano is a chemistry technology company that provides chemists solutions for making new chemistry possible, dangerous chemistry safer, and slow chemistry faster. Market leader: >700 customer install base on 6 continents. Own chemistry team. 10 years old-most established flow reactor company.

5. ThalesNano Markets & Track Record Agrochemical Flavours & Fragrance Petrochemical Pharmaceutical Biotech Food, Forensics New Markets 2005 Chicago based R&D 100 Innovation’s Oscar Award 2006 Hungarian Innovation Award 2007 The Fastest Developing Venture, Hungarian Venture Capital Association 2008 Deployed in Top 20 Pharma companies 2010 Millennium Award, Hungarian Patent Office

6. Who are our customers? (>700 worldwide)  20 out of 20 Top Pharmaceutical  5 out of 10 agrochemical companies  4 out of Top 5 Fragrance companies  Petrochemical emerging  International R&D Top 100 Award Winner!  Over 150 publications.

7. What is flow chemistry? OR Pump Reactor Collection Advantages: Temperature control Selectivity Reproducibility Higher temperature and pressure capabilities

8. Product Portfolio H-Cube Pro™ 150°C, 100 bar Hydrogenation No H2 cylinders-just H 2 O Selective C-C coupling Gas Module Other gas reactions CO, CO/H 2, C 2 H 4, CO2 Up to 1450 psi Safe and simple to use Phoenix Flow Reactor 450°C, 1450 psi Chemistry in seconds Novel heterocycles 150°C, 100 bar, 5 mins 99% Yield. >300°C, T3P, 100 bar, 5 mins 65% Yield. No result below 300°C 140°C, 100 bar, 1% Au/TiO 2, O 2, 5 mins 99% Conversion + Selectivity

9. Halogenation Nitration Azides -40°C App Chip/Loop Modular Lithiation Ozonolysis Exothermic Reactions

10. H-Cube Midi™ reactor for scale-up Kilo Scale

11. Belső innováció és piacralépés 1.Belső innovációs rendszer létrehozása 2.Piaci igénnyel összehozni 3.Prototius 4. alfa béta teszt, első piaci visszajelzések 5. Végtermék kialakitása 6. Piacra vitel előkészitése, marketing 7. Első piaci sikerek után megfontolni a leválasztást, a növekedéshez befektető bevonását előkésziteni